Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions. - Pradeep, C-R; Zeisel, A; Köstler, W J; Lauriola, M; Jacob-Hirsch, J; Haibe-Kains, B; Amariglio, N; Ben-Chetrit, N; Emde, A; Solomonov, I; Neufeld, G; Piccart, M; et al. (Oncogene, 2012)